glp 1 and restless leg syndrome Periodic Limb Movement Disorder (PLMD): Genes and Solutions 🦵 RESTLESS LEGS SYNDROME (RLS)

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

New JAMA Study Links Wegovy to NAION A JAMA study published on July 3, 2024, on the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide found an increased risk of the condition in patients taking semaglutide compared to those taking non-GLP-1 RA medications

Tirzepatide activates both GLP-1 and GIP receptors, while semaglutide only activates GLP-1 receptors

The study found that newer GLP-1 RAs were associated with reduced risk of alcohol-related hospitalization across clinically distinct populations

Baz beslenme ve yaam tarz alkanlklar GLP-1 sisteminin daha zayf almasna neden olabilir

GLP-1 Medicaid coverage is changing rapidly